Hcw Biologics (HCWB)Officer bought ~$20K

~$20K

Approx. value · 7,736 sh @ $2.59

8,691

Holds after · shares reported

Traded

Jul 29, 2026

Filed

Jul 31, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 29, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“As previously disclosed, on March 26, 2026, HCW Biologics Inc. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that for 30 consecutive business days, the Company’s listed securities did not maintain a minimum bid price of $1 per share, in accordance with Nasdaq Listing Rule 5550(a)(2) (“Bid Price Rule”) for continued listing on The…”
2. Jun 24, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
3. Jun 29, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On June 29, 2026, HCW Biologics Inc. (the “Company”) received written notice form the Listing Qualifications Staff (the “Staff”) of the Nasdaq Capital Market Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) found that the Company regained compliance with Listing Rule 5550(a)(2), the “Bid Price Rule,” per the terms set forth in the Panel’s decision letter dated May 29, 2026, as amended.”
4. Jul 29, 2026 · this disclosureInsider · 3 insiders in a week, 8th time since 2021Officer purchased ~$20K of HCWB shares in the open market

What came next

1. Jul 29, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 2 more items)
2. Jul 29, 2026Insider · 2 peopleInsiders: 2 purchases (~$80K)
3. Aug 10, 2026Company filing · Form 8-K · RestatementSaid past financial statements can no longer be relied on
4. Aug 14, 2026Company filing · Form 8-K · ResultsReported its results
5. Sep 4, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
6. Sep 23, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 2 more items)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hcw Biologics

For Hcw Biologics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCWB page.

Other recent filings by Lee Flowers, SVP of Business Development

• SEC Form 4 at Hcw Biologics (HCWB)May 9, 2025

The full history of Lee Flowers, SVP of Business Development is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Hcw Biologics

• SEC Form 4Jul 31, 2026
• SEC Form 4Jul 31, 2026
• SEC Form 4May 27, 2026
• SEC Form 4May 27, 2026
• SEC Form 4May 27, 2026
• SEC Form 4May 20, 2025

Everything OQRO holds on this company is on its HCWB page.